-transparent.png){kind=logo}
Forty-seven women with regular ovulatory menstrual cycles and normal plasma prolactin levels were treated with different doses of bromocriptine, and changes in follicular and luteal phase length determined by daily estimation of plasma gonadotrophin concentration. Follicular phase length was highly significantly reduced from a median duration of 12.7 days in the basal cycle to 11.7 days in the first treatment cycle, and to 10.7 days during the second treatment cycles. The length of the luteal phase was unaltered by treatment with bromocriptine. Reduction of follicular phase length was not influenced by the dose of bromocriptine used, and it is concluded that this effect is a consequence of the reduction of plasma prolactin concentration.
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
May 2000,
Journal of acquired immune deficiency syndromes (1999),
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
April 1995,
Human biology,
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
January 1968,
British medical journal,
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
January 1965,
Lancet (London, England),
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
January 1997,
Journal of alternative and complementary medicine (New York, N.Y.),
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
October 1997,
Obstetrics and gynecology,
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
August 1942,
Edinburgh medical journal,
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
June 2005,
Addiction (Abingdon, England),
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
January 2008,
American journal of epidemiology,
S K Smith, and
O Sobowale, and
E A Lenton, and
I D Cooke
March 2007,
Annals of epidemiology,
